| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16,4 M € | +13.3% | 14,5 M € | +1.6% | 14,2 M € | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||
| Gross margin | — | — | — | 598,4 k € | +33.6% | 447,8 k € | -38.6% | 729,3 k € | +38.8% | 525,6 k € | -7.5% | 568,0 k € | +63.4% | 347,7 k € | -7.2% | 374,8 k € | -31.3% | 545,6 k € | +15.7% | 471,7 k € | -16.5% | 565,0 k € | +26.8% | 445,6 k € | -21.9% | 570,3 k € | -43.8% | 1,0 M € | +107.4% | 489,2 k € | -1.9% | 498,6 k € | ||||
| EBITDA | 2,3 M € | +46.4% | 1,6 M € | +1.0% | 1,6 M € | +1158.5% | 125,3 k € | +88.5% | 66,4 k € | -76.9% | 287,8 k € | +171.1% | 106,2 k € | -53.2% | 227,1 k € | +79.1% | 126,8 k € | -13.1% | 145,9 k € | -35.1% | 224,8 k € | +3.8% | 216,5 k € | +182.4% | 76,7 k € | +355.1% | -30,1 k € | +67.9% | -93,8 k € | -128.4% | 330,7 k € | +283.0% | 86,3 k € | -44.4% | 155,4 k € | |
| Operating profit | 1,5 M € | +215.3% | -1,3 M € | -34.6% | -934,7 k € | -1609.8% | 61,9 k € | +266.8% | -37,1 k € | -120.1% | 184,8 k € | +316.6% | 44,4 k € | -77.4% | 195,9 k € | +49.2% | 131,3 k € | +359.1% | 28,6 k € | -42.4% | 49,7 k € | -68.8% | 159,2 k € | +194.6% | 54,0 k € | +31.4% | 41,1 k € | +127.9% | -147,2 k € | -251.5% | 97,2 k € | +63.3% | 59,5 k € | -61.1% | 153,1 k € | |
| Profit/loss | 1,0 M € | +201.5% | -1,0 M € | +9.0% | -1,1 M € | -190.3% | 1,2 M € | +3960.2% | -31,8 k € | -101.3% | 2,5 M € | +16.0% | 2,1 M € | +109.7% | 1,0 M € | +1203.5% | 78,4 k € | +549.1% | 12,1 k € | -32.3% | 17,8 k € | -86.7% | 134,5 k € | +464.2% | 23,8 k € | +78.1% | 13,4 k € | +106.7% | -198,9 k € | -5797.5% | 3,5 k € | -93.5% | 54,0 k € | -50.0% | 108,1 k € | |
| Equity | 6,0 M € | -6.6% | 6,4 M € | -30.1% | 9,2 M € | -25.2% | 12,3 M € | -1.0% | 12,5 M € | -0.3% | 12,5 M € | +24.9% | 10,0 M € | +27.3% | 7,9 M € | +15.0% | 6,8 M € | +588.8% | 992,3 k € | +1.2% | 980,2 k € | +1.9% | 962,3 k € | +16.2% | 827,9 k € | +3.0% | 804,0 k € | +1.7% | 790,6 k € | -20.1% | 989,5 k € | +0.4% | 986,0 k € | +5.8% | 932,0 k € | |
| Total assets | 10,6 M € | +5.6% | 10,1 M € | -25.8% | 13,6 M € | -6.8% | 14,6 M € | +4.5% | 14,0 M € | -9.0% | 15,3 M € | +10.8% | 13,8 M € | +6.0% | 13,1 M € | +3.7% | 12,6 M € | +607.1% | 1,8 M € | +1.4% | 1,8 M € | -6.0% | 1,9 M € | -5.4% | 2,0 M € | -16.2% | 2,4 M € | -12.2% | 2,7 M € | +8.3% | 2,5 M € | +5.7% | 2,3 M € | +0.7% | 2,3 M € | |
| Cash | 251,9 k € | +13.2% | 222,4 k € | -78.7% | 1,0 M € | +410.6% | 204,1 k € | -4.3% | 213,3 k € | -32.7% | 316,8 k € | +123.5% | 141,7 k € | -52.8% | 300,5 k € | -14.0% | 349,2 k € | -21.1% | 442,9 k € | +35.8% | 326,1 k € | -1.0% | 329,5 k € | +23.7% | 266,3 k € | +37.4% | 193,8 k € | +44.2% | 134,3 k € | -20.6% | 169,1 k € | -43.0% | 296,4 k € | +5.8% | 280,2 k € | |
| Debts | 4,6 M € | +32.7% | 3,5 M € | -19.0% | 4,3 M € | +96.2% | 2,2 M € | +46.3% | 1,5 M € | -47.5% | 2,8 M € | -26.0% | 3,8 M € | -26.2% | 5,2 M € | -9.8% | 5,8 M € | +630.2% | 787,5 k € | +1.6% | 775,0 k € | -14.3% | 904,4 k € | -21.0% | 1,1 M € | -26.1% | 1,5 M € | -18.0% | 1,9 M € | +27.1% | 1,5 M € | +12.7% | 1,3 M € | -5.5% | 1,4 M € | |
| Staff | 13 | 14 | 13,1 | 5,9 | 5,2 | 6,5 | 6,7 | 5 | 3,8 | 4 | 3,4 | 4,4 | 7,8 | 8,3 | 12,3 | 10,3 | 7,9 | 7 | ||||||||||||||||||
Public limited company · Herzele · incorporated on 09/12/1987 · 13,0 ETP
Public limited company profitable and well capitalised. Cash position rising (+13.2%).
Solid counterparty for a standard engagement.
BeMedico is a Public limited company incorporated in 1987. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Herzele. It employs on average 13,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette